Clinical Trial Search block Test
A single-arm, open-label, prospective, multicenter safety study to evaluate the occurrence of essential fatty acid deficiency (EFAD) in pediatric patients with parenteral nutrition-associated cholestasis (PNAC) who require more than eight weeks of Omegaven treatment
Omegaven
What is the goal of the study?
Multicenter, prospective, open-label, primarily observational safety study designed to evaluate the occurrence of essential fatty acid deficiency (EFAD) in pediatric patients with parenteral nutrition-associated cholestasis (PNAC) who are expected to require more than eight weeks of Omegaven treatment
Who can participate in the study?
Everyone